1 to 6 and 10, or a decreased expression level of the gene characterised by any of SEQ ID Nos. 7 to 9, indicates the presence of or the risk of cancer in the patient from whom the sample was isolated.Martin Andrew CrockardJohn Victor LamontStephen Peter Fitzgerald...
右图:使用抗TPD52 (HPA062167) 抗体对乳腺导管癌(女性,62 岁)进行的免疫组织化学染色,结果肿瘤细胞的细胞质/膜染色现中度染色,呈棕色。 作为专业的生命科学与医药产品方案供应商,艾美捷科技为您推荐:Atlas Antibodies提供一系列的抗体来检测乳腺癌的特异性标志物(Brea...
AVerring A, Clouth P, Ziolkowski, Oremek GM (2011) Clinical usefulness of cancer marker in primary breast cancer. International Scholarly Research Network ISRN Pathology.Verring A, Clouth A, Ziolkowski P, Oremek GM. Clinical useful- ness of cancer markers in primary breast cancer. ISRN Pathol...
Breast cancer markers,乳腺癌标志物 乳腺癌(breast cancer,BC)是发生于乳腺腺上皮组织的恶性肿瘤,是妇女最常见的恶性肿瘤之一。近年来,乳腺癌发病率呈明显上升趋势,流行病学调查表明25～35岁乳腺癌发病大幅增加。 生物标志物可以帮助临床医师对乳腺癌预后和有/无复发及转移作出更准确的判断,并能指导临床选择更为行之...
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view — it ...
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view — it ...
(HealthDay)—Breast cancer tumor markers are frequently used for routine surveillance in nonmetastatic breast cancer, and their use has been found to increase the number of diagnostic procedures performed as well as the total cost of care, according to a study published online Oct. 20 in theJou...
Currently, several neoadjuvant therapy regimens for breast ca... M Kurosumi - 《Breast Cancer》 被引量: 81发表: 2006年 Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. The potential prognostic value of stem cell markers is ...
Markers for breast cancerCorrelations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators ...
protein biomarker Stat5 have an increased likelihood of responding to tamoxifen. In contrast, women treated with tamoxifen whose tumors lacked active Stat5 had up to a 20-fold increased risk of dying frombreast cancerafter adjustment for effects of standardhormone receptormarkers and other pathology ...